Skip to main navigation
Loading
  • News
  • Investors
  • Careers
  • Contact
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home
  • Menu Menu

SEC Filings

  • Overview
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Press Releases
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • IRS – Required Disclosures
  • SEC Filings
    • Quarterly Results
  • Contact
  • Email Alerts
Filing date Form Description Filing Group View
05-06-2008 REGDEX

REGDEX

Other
9999999997-08-023225.rtf
9999999997-08-023225.pdf
View HTML
05-01-2009 D

Notice of Exempt Offering of Securities

Other
0001181431-09-022056.rtf
0001181431-09-022056.xls
0001181431-09-022056.pdf
View HTML
08-27-2009 D/A
Other
0001181431-09-041482.rtf
0001181431-09-041482.xls
0001181431-09-041482.pdf
View HTML
07-15-2010 D

Notice of Exempt Offering of Securities

Other
0001181431-10-037508.rtf
0001181431-10-037508.xls
0001181431-10-037508.pdf
View HTML
06-30-2011 D/A
Other
0001181431-11-038899.rtf
0001181431-11-038899.xls
0001181431-11-038899.pdf
View HTML
05-30-2013 D

Notice of Exempt Offering of Securities

Other
0001434647-13-000003.rtf
0001434647-13-000003.xls
0001434647-13-000003.pdf
View HTML
12-19-2014 DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Registration Statements
0000950123-14-012811.rtf
0000950123-14-012811.xls
0000950123-14-012811.pdf
View HTML
01-15-2015 UPLOAD

UPLOAD

Other
0000000000-15-002183.pdf
View HTML
01-26-2015 DRS/A

mendment to a previously filed DRS

Registration Statements
0000950123-15-000420.rtf
0000950123-15-000420.xls
0000950123-15-000420.pdf
View HTML
02-10-2015 UPLOAD

UPLOAD

Other
0000000000-15-008513.pdf
View HTML
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »

Data provided by Kaleidoscope.

  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
  • Our Approach
    • What We Do
    • Partnering
  • Patients & Providers
    • Niemann-Pick Disease Type C
    • Sleep Disorders
    • Expanded Access Policy
  • Science & Pipeline
    • Pipeline
    • Clinical Trials
    • Products
    • Publications & Presentations
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Information
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home

© 2023 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use

Scroll to top